Indeed, we recently reported that early inhibition of SEH with the orally active inhibitor 12-(3-adamantan-1-yl-ureido)-dodecanoic acid (AUDA) could prevent programmed hypertension in the dexamethasone and high fructose models [26,57]. The gene discussed is EPHX2; the disease is hypertensive disorder.